Table 3. Pathological information of study participants.
| Variable (n = 113) | Frequency (%) |
|---|---|
|
Primary site of disease Left Right Bilateral |
49 (43.4) 59 (52.2) 5 (4.4) |
|
Bilateral type (n = 5) Metachronous Synchronous |
3 (60.0) 2 (40.0) |
|
Histological type Invasive ductal carcinoma Invasive lobular carcinoma Others (Medullary, mucinous, papillary, metastatic) |
101 (89.4) 6 (5.3) 6 (5.3) |
|
Grade of breast cancer (n = 106) I II III |
17 (16.0) 67 (63.2) 22 (20.8) |
|
Tumour size T1 T2 T3 T4 |
4 (3.6) 15 (13.3) 45 (39.8) 49 (43.4) |
|
Nodal status N0 N1 N2 N3 |
9 (8.0) 52 (46.0) 49 (43.4) 3 (2.7) |
|
Stage of disease I II III IV |
4 (3.5) 7 (6.2) 81 (71.7) 21 (18.6) |
|
Metastatic sitea (n = 21) Bone Liver Lungs |
2 (9.5) 5 (23.8) 18 (85.7) |
|
Immunohistochemistry ER+ PR+ HER-2+ HER-2 equivocal Triple negative |
36 (41.9) 22 (25.6) 15 (17.4) 4 (4.7) 40 (46.5) |
a
Multiple options allowed